Literature DB >> 2860067

Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors.

S N Abraham, J P Babu, C S Giampapa, D L Hasty, W A Simpson, E H Beachey.   

Abstract

Hybridoma antibodies directed against quaternary structural epitopes of the type 1 fimbrial adhesin of Escherichia coli or against D-mannose, the sugar determinant in the complementary host cell receptor, prevented the attachment of mannose-sensitive E. coli to various eucaryotic cells. Passive intraperitoneal administration of the fimbria-specific or D-mannose-specific antibodies protected mice against retrograde colonization with mannose-sensitive E. coli instilled into their urinary bladders. Monoclonal antibodies directed against fimbrial subunits rather than quaternary structural epitopes or against N-acetylgalactosamine rather than D-mannose residues lacked protective activity. These studies provide evidence that bacterial colonization can be blocked or interrupted by antibodies directed against either the adhesin or the complementary host cell receptor of pathogenic microorganisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860067      PMCID: PMC261209          DOI: 10.1128/iai.48.3.625-628.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.

Authors:  I Ofek; D Mirelman; N Sharon
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

2.  Antibody-coated bacteria in the urine and the site of urinary-tract infection.

Authors:  V Thomas; A Shelokov; M Forland
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

3.  Protection against experimental pyelonephritis by antibodies to pili.

Authors:  F J Silverblatt; R Weinstein; P Rene
Journal:  Scand J Infect Dis Suppl       Date:  1982

4.  Antipili antibody affords protection against experimental ascending pyelonephritis.

Authors:  F J Silverblatt; L S Cohen
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

5.  Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice.

Authors:  T Iwahi; Y Abe; M Nakao; A Imada; K Tsuchiya
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

Review 6.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

7.  Effect of piliation on Klebsiella pneumoniae infection in rat bladders.

Authors:  R C Fader; C P Davis
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

8.  Type I Escherichia coli pili: characterization of binding to monkey kidney cells.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

9.  Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis.

Authors:  W F Keane; L R Freedman
Journal:  Yale J Biol Med       Date:  1967-12

10.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  33 in total

1.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.

Authors:  K Thankavel; B Madison; T Ikeda; R Malaviya; A H Shah; P M Arumugam; S N Abraham
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  The two-component response regulator RcsB regulates type 1 piliation in Escherichia coli.

Authors:  William R Schwan; Satoshi Shibata; Shin-Ichi Aizawa; Alan J Wolfe
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

4.  TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder.

Authors:  Jeongmin Song; Brian L Bishop; Guojie Li; Matthew J Duncan; Soman N Abraham
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

5.  Urinary tract infection drives genome instability in uropathogenic Escherichia coli and necessitates translesion synthesis DNA polymerase IV for virulence.

Authors:  Damian Gawel; Patrick C Seed
Journal:  Virulence       Date:  2011-05-01       Impact factor: 5.882

Review 6.  Pathogenic factors in recurrent urinary tract infections and renal scar formation in children.

Authors:  W Mannhardt; O Schofer; H Schulte-Wissermann
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

Review 7.  Enterobacterial fimbriae.

Authors:  S Clegg; G F Gerlach
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

Review 8.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

9.  Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding.

Authors:  P W Russell; P E Orndorff
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

10.  Functional heterogeneity of type 1 fimbriae of Escherichia coli.

Authors:  E V Sokurenko; H S Courtney; S N Abraham; P Klemm; D L Hasty
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.